Dr. Jayan Nair, MD

Dr. Nair practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Nair's NPI, 1932280138, was assigned on October 17, 2006. Dr. Nair graduated from TD Medical College Kerala in 1997. Dr. Nair holds Florida license ME104292.

Dr. Nair's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Nair's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Nair is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Nair to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nair practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Nair's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Nair is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Nair's licenses on file in 3 states: Florida, Minnesota and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Nair treats.

CMS data shows 62,743 Medicare services from Dr. Nair across 43 procedure codes in 2024, for 1,150 Medicare patients. Medicare paid $1,041,549 for them.

CMS counts 1,150 Medicare patients who saw Dr. Nair in 2024. The largest group is 75 to 84, with 508 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nair's median patient age at 73, with 53% women.

In 2024, Dr. Nair wrote 573 Medicare Part D claims for 136 patients. 70% of them were for generic drugs. CMS names the drug for 331 of them, across 17 drugs with 11 or more claims each, at $1,637,904 in total drug cost. In 2023, CMS named 118 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nair for performance year 2024, reported as part of a group. Dr. Nair accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nair as offering telehealth.

Dmand AI links 3 papers to Dr. Nair, published from 2010 to 2015. Dr. Nair's most frequent co-authors are Thomas J. George, MD, Gabriel Noah Mannis, MD and Robert A. Zlotecki, MD.

CMS Open Payments shows 599 general payments to Dr. Nair from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Merck Sharp & Dohme Corporation paid the most, $1,264.

Dmand AI lists 1 award for Dr. Nair, most recently CMS Stage 1 EHR in 2013.

Dr. Nair graduated from TD Medical College Kerala in 1997.

Dr. Nair is in network with 18 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.